XML 49 R37.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ (Deficit) Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Stockholders’ (Deficit) Equity [Abstract] |
Schedule of Common stock Underlying the Warrants Activity | A summary of the Common Stock underlying the warrants activity (including both liability and equity classified instruments) is presented below (in thousands, except number of shares, exercise price, and years data):
|  | Three Months Ended March 31, 2026 |
|  | Number of Shares of Common Stock Underlying Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life in Years |  |  | Intrinsic Value |
Outstanding, December 31, 2025 |  |  | 7,020,932 |  |  | $ | 22.47 |  |  |  | - |  |  | $ | 7,607 |
Issued |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | (270 | ) |  |  | 43,499.00 |  |  |  | - |  |  |  | - |
Outstanding, March 31, 2026 |  |  | 7,020,662 |  |  | $ | 22.47 |  |  |  | - |  |  | $ | 7,607 |
Exercisable, March 31, 2026 |  |  | 7,020,662 |  |  | $ | 22.47 |  |  |  | - |  |  |  | - |
Schedule of Outstanding and Exercisable Common Stock Underlying the Warrants | A summary of outstanding and exercisable Common Stock underlying the warrants is presented below:
March 31, 2026 |
Common Stock Underlying Warrants Outstanding |  |  | Common Stock Underlying Warrants Exercisable |
Exercise Price |  |  | Number of Shares |  |  | Weighted Average Remaining Life in Years |  |  | Number of Shares |
$ | 34.45 |  |  |  | 907,115 |  |  |  | N/A |  |  |  | 907,115 |
$ | 32.30 |  |  |  | 405 |  |  |  | N/A |  |  |  | 405 |
$ | 27.75 |  |  |  | 4,557,223 |  |  |  | N/A |  |  |  | 4,557,223 |
$ | 26.50 |  |  |  | 270 |  |  |  | 0.4 |  |  |  | 270 |
$ | 22.80 |  |  |  | 75 |  |  |  | 4.25 |  |  |  | 75 |
$ | 0.01 |  |  |  | 1,555,574 |  |  |  | N/A |  |  |  | 1,555,574 |
|  |  |  |  | 7,020,662 |  |  |  | 0.0 |  |  |  | 7,020,662 |

X
- Definition Tabular disclosure of warrants exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under warrants, weighted average exercise price and remaining contractual terms. + References No definition available. + Details
Name: | ethz_ScheduleOfShareBasedCompensationSharesAuthorizedUnderWarrantsPlansByExercisePriceRangeTextBlock
Namespace Prefix: | ethz_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration